IRCT20181219042047N1
Effect of Epigallocatechin Gallate supplementation on type 2 diabetes
Effects of Epigallocatechin Gallate Supplementation on the Insulin Resistence and Inflammatory Factors in Patients with Type 2 Diabetes
Artesh University of Medical Sciences·Iranian Registry Of Clinical Trial·drugCompleted
Study focus
- Disease/Condition
- Non-insulin-dependent diabetes mellitus
- Study type
- Interventional
- Intervention type
- drug
Sponsor & location
- Primary sponsor
- Artesh University of Medical Sciences
- Location
- Iran
Timeline & enrollment
- Phase
- N/A
- Start date
- Dec 11, 2018
- End date
- N/A
ICD-10 classifications
Other specified diabetes mellitus without complicationsUnspecified diabetes mellitus without complicationsOther specified diabetes mellitusOther specified diabetes mellitus with other specified complicationsOther specified diabetes mellitus with unspecified complications
Data source
- Registry
- Iranian Registry Of Clinical Trial
- Trial ID
- IRCT20181219042047N1
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for IRCT20181219042047N1 through Pure Global AI's free database. This phase not specified trial is sponsored by Artesh University of Medical Sciences and is currently Completed. The study focuses on Non-insulin-dependent diabetes mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.